NYSE$ENOV

Enovis Corp · Q4 2020 earnings

Q4 2020 earnings · · Investor relations

Briefing

Colfax reported Q4 2020 results, achieving $0.29 EPS and $0.51 adjusted EPS.

Colfax Corporation announced strong Q4 2020 results with net sales of $828 million and adjusted EPS of $0.51. The company also completed the acquisition of two medical technology businesses and provided a positive 2021 growth outlook.

  • Reported $0.29 EPS from continuing operations and achieved $0.51 of adjusted EPS.
  • Net sales increased to $828 million, a 3% sequential increase from Q3 2020.
  • Generated operating cash flow of $129 million and free cash flow of $96 million.
  • Announced 2021 outlook with expectations for significant revenue, profit, and cash flow growth.

Headline financials

Total Revenue

$828M

Previous: $888M-6.8%
EPS (adj)

$1.53

Previous: $1.83-16.4%
Capital Expenditures

$33.2M

Previous: $25M+32.7%
Free Cash Flow

$96M

Previous: $40.2M+138.9%
Net Income

$41.5M

Previous: $34.4M+20.7%
Operating Income

$58.4M

Previous: $91.9M-36.4%
Gross Profit

$355M

Previous: $396M-10.4%
Cash & Equivalents

$97.1M

Previous: $110M-11.5%
Total Assets

$7.35B

Previous: $7.39B-0.5%
Stock-Based Comp

$7.27M

Previous: $4.96M+46.7%

Revenue & EPS history

Enovis · Revenue · Quarterly

$828M

Q4 2020-6.8%vs Q4 2019
Beat estimate in 15 of 16 quarters(94%)
ActualEstimate

Revenue by segment

Enovis · $131M total across 1 segment · Q2 2022

  • Reconstructive
    $131M

Forward guidance

Colfax expects significant growth in sales, earnings and cash flow in 2021.

Tailwinds

  • Revenue is expected to grow 15-18% from the prior year.
  • Adjusted earnings to grow at least 44% to $2.00 to $2.15 per diluted share.
  • Projecting free cash flow of $250 million or more.
  • Expects adjusted earnings of $0.35 to $0.40 per diluted share for Q1 2021.
  • Sequentially improving throughout the year due to seasonality and expected recovery in customer demand.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2020

Historical avgQ4 2020

+1.6%

Avg return

Earnings day

+1.3%

Avg return

5 days after

+0.1%

Avg return

30 days after

52%

33 / 64 earnings

Positive

+21.3%

Q3 2011

Best reaction

-18.7%

Q1 2016

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+9.7%+4.0%-4.5%
Q4 2025+13.8%+13.3%-2.2%
Q3 2025-9.7%+0.1%-14.2%
Q1 2025-2.9%+9.1%-7.2%
Q4 2024-4.9%-10.1%-10.3%
Q3 2024+10.6%+9.3%+10.0%
Q2 2024+4.0%+1.0%+3.5%
Q1 2024-7.5%-5.7%-9.3%
Q4 2023+4.3%+2.0%-0.1%
Q3 2023+4.0%+3.2%+8.8%
Q2 2023-5.6%-8.1%-10.0%
Q1 2023-1.8%-3.7%-3.9%
Q4 2022-9.6%-6.4%-18.9%
Q3 2022-3.4%+7.4%+15.9%
Q2 2022-3.7%-4.4%-17.5%
Q1 2022+5.7%+5.9%+7.4%
Q4 2021+0.9%+2.8%-3.7%
Q3 2021+0.4%-1.4%-14.9%
Q2 2021+3.6%+2.1%+8.5%
Q1 2021-1.1%-5.9%-3.2%
Q4 2020+13.7%+17.2%+16.8%
Q3 2020-4.1%+3.0%+30.8%
Q2 2020+6.8%+13.0%+8.1%
Q1 2020+14.6%+6.6%+33.4%
Q4 2019+2.8%-5.1%-55.3%
Q3 2019+9.6%+11.5%+6.0%
Q2 2019+7.9%+5.3%+15.1%
Q1 2019-5.5%-6.5%-4.7%
Q4 2018+5.3%+6.8%+15.0%
Q3 2018-0.3%+0.8%-12.5%
Q2 2018+5.5%+0.8%+12.9%
Q1 2018+2.2%+5.3%+1.1%
Q4 2017-8.5%-14.2%-11.2%
Q3 2017-12.7%-13.7%-14.0%
Q2 2017+1.1%+0.9%-4.3%
Q1 2017+1.9%+2.4%+7.4%
Q4 2016+2.2%-0.5%-5.0%
Q3 2016+7.8%+5.4%+26.9%
Q2 2016+0.0%-3.2%+3.4%
Q1 2016-18.7%
Q4 2015+18.9%
Q3 2015-6.5%
Q2 2015-5.1%
Q1 2015-0.8%
Q4 2014-0.9%
Q3 2014-5.1%
Q2 2014-6.9%
Q1 2014-3.4%
Q4 2013+7.0%
Q3 2013+0.0%
Q2 2013-0.1%
Q1 2013+4.5%
Q4 2012-5.8%
Q3 2012-2.7%
Q2 2012+5.2%
Q1 2011-5.7%
Q1 2012+1.3%
Q4 2011-1.9%
Q3 2011+21.3%
Q2 2011+16.2%
Q4 2010+16.2%
Q2 2010+16.2%
Q3 2010+1.0%
Q1 2010+0.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro